Adolescent hyperandrogenism: diagnostic challenges and therapeutic approaches

Chillarón JJ. Hirsutism: diagnosis and treatment. FMC Form Med Contin Aten Primaria. 2020;27:11–3 (in Spanish).

Google Scholar 

Zhang T, Xu Y. Exploration of the clinical pathway for etiological diagnostics of androgen excess in female. Zhonghua Yi Xue Za Zhi. 2023;103:1016–21 (in Chinese).

CAS  PubMed  Google Scholar 

Witchel SF. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. 2017;30:520–34.

Article  PubMed  PubMed Central  Google Scholar 

Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS teenagers: a follow-up comparison between Myo-inositol and oral contraceptives. Eur Rev Med Pharmacol Sci. 2021;25:7476–85.

CAS  PubMed  Google Scholar 

Sıklar Z, Berberoğlu M, Çamtosun E, Kocaay P. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence. J Pediatr Adolesc Gynecol. 2015;28:78–83.

Article  PubMed  Google Scholar 

Sardana K, Muddebihal A, Sehrawat M, Bansal P, Khurana A. An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists. Expert Rev Endocrinol Metab. 2024;19:111–28.

Article  CAS  PubMed  Google Scholar 

Esquivel-Zuniga MR, Kirschner CK, McCartney CR, Burt Solorzano CM. Non-PCOS hyperandrogenic disorders in adolescents. Semin Reprod Med. 2022;40:42–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bizuneh AD, Joham AE, Teede H, Mousa A, Earnest A, Hawley JM, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Hum Reprod Update. 2025;31:48–63.

Article  CAS  PubMed  Google Scholar 

Makrantonaki E, Zouboulis CC. Hyperandrogenism, adrenal dysfunction, and hirsutism. Hautarzt. 2020;71:752–61 (in German).

Article  CAS  PubMed  Google Scholar 

Reinehr T, Dieris B. New clinical practice guideline for evaluation and treatment of children and adolescents with obesity: paradigm shifts. Lancet Diabetes Endocrinol. 2023;11:222–3.

Article  PubMed  Google Scholar 

Bulsara J, Patel P, Soni A, Acharya S. A review: brief insight into polycystic ovarian syndrome. Endocr Metab Sci. 2021;3:100085.

Article  CAS  Google Scholar 

Kiconco S, Earnest A, Enticott J, Hart R, Mori TA, Hickey M, et al. Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis. Eur J Endocrinol. 2023;188:494–502.

Article  CAS  PubMed  Google Scholar 

Rojewska P, Meczekalski B, Bala G, Luisi S, Podfigurna A. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach. Gynecol Endocrinol. 2022;38:537–42.

Article  CAS  PubMed  Google Scholar 

Nowak-Ciołek M, Stachowiak JJ, Krok K, Sokal J, Malczyk Ż, Skrzyńska K, et al. Adolescent PCOS and long-term metabolic risk: insights from triglycerides to high-density lipoprotein cholesterol ratio and high-density lipoprotein cholesterol profiles. Front Endocrinol (Lausanne). 2025;16:1579217.

Article  PubMed  Google Scholar 

Tay CT, Hart RJ, Hickey M, Moran LJ, Earnest A, Doherty DA, et al. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020;18:389.

Article  PubMed  PubMed Central  Google Scholar 

Conlon JL, Malcolm S, Monaghan M. Diagnosis and treatment of polycystic ovary syndrome in adolescents. JAAPA. 2021;34:15–22.

Article  PubMed  Google Scholar 

Akgül S, Düzçeker Y, Kanbur N, Derman O. Do different diagnostic criteria impact polycystic ovary syndrome diagnosis for adolescents? J Pediatr Adolesc Gynecol. 2018;31:258–62.

Article  PubMed  Google Scholar 

Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108:2447–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azziz R, Amiri M, Bril F, Joham AE, Kelestimur F, Ottey S, et al. Approach to the patient: hirsutism. J Clin Endocrinol Metab. 2025. https://doi.org/10.1210/clinem/dgaf226.

Article  PubMed  PubMed Central  Google Scholar 

Merke DP, Auchus RJ. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 2020;383:1248–61.

Article  CAS  PubMed  Google Scholar 

Auer MK, Nordenström A, Lajic S, Reisch N. Congenital adrenal hyperplasia. Lancet. 2023;401:227–44.

Article  CAS  PubMed  Google Scholar 

Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:4043–88.

Article  PubMed  PubMed Central  Google Scholar 

Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S, et al. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update. 2017;23:580–99.

Article  CAS  PubMed  Google Scholar 

Falhammar H, Nordenström A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 2015;50:32–50.

Article  CAS  PubMed  Google Scholar 

Rowe NE, Kumar R, Schieda N, Siddiqi F, McGregor T, McAlpine K, et al. Diagnosis, management, and follow-up of the incidentally discovered adrenal mass: CUA guideline endorsed by the AUA. J Urol. 2023;210:590–9.

Article  PubMed  Google Scholar 

Practice Committee of the American Society for Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril. 2006;86(5 Suppl 1):S241–7.

Google Scholar 

Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382:937–50.

Article  CAS  PubMed  Google Scholar 

Bavaresco A, Mazzeo P, Lazzara M, Barbot M. Adipose tissue in cortisol excess: what Cushing’s syndrome can teach us? Biochem Pharmacol. 2024;223:116137.

Article  CAS  PubMed  Google Scholar 

Nowotny HF, Braun L, Reisch N. The landscape of androgens in Cushing’s syndrome. Exp Clin Endocrinol Diabetes. 2024;132:670–7.

Article  CAS  PubMed  Google Scholar 

Nowotny HF, Braun L, Vogel F, Bidlingmaier M, Reincke M, Tschaidse L, et al. 11-oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease. Eur J Endocrinol. 2022;187:663–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2019;502:214–21.

Article  PubMed  Google Scholar 

Hernández-Jiménez JL, Barrera D, Espinoza-Simón E, González J, Ortíz-Hernández R, Escobar L, et al. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2021;38:2–9.

Article  PubMed  Google Scholar 

Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, De Courten B, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf). 2018;89:628–33.

Article  CAS 

Comments (0)

No login
gif